Aptorum Group Ltd share price today

(APM)

Aptorum Group Ltd share price is $0.75 & ₹63.55 as on 6 Dec 2024, 2.30 'hrs' IST

$0.75

▲

0.02

(3.24%)

Market is closed - opens 8 PM, 06 Dec 2024

View live Aptorum Group Ltd share price in Dollar and Rupees. Guide to invest in Aptorum Group Ltd from India. Also see the sentimental analysis on Indian investors investing in Aptorum Group Ltd. Get details on the Indian mutual funds that are investing in Aptorum Group Ltd. Get Analyst recommendations and forecasts along with all the Aptorum Group Ltd's financials.

Aptorum Group Ltd share price movements

$0.65
$0.75
$0.75
12.93%
Downside
Day's Volatility :12.93%
Upside
0.0%
$0.46
$17.49
$0.75
38.67%
Downside
52 Weeks Volatility :97.37%
Upside
95.71%

Aptorum Group Ltd Returns

Period	Aptorum Group Ltd	Index (Russel 2000)
3 Months	-72.02%	0.0%
6 Months	-80.8%	0.0%
1 Year	-56.89%	0.0%
3 Years	-94.88%	-18.1%

Aptorum Group Ltd Key Statistics

in dollars & INR

Previous Close	$0.7221
Open	$0.7156
Today's High	$0.75
Today's Low	$0.653
Market Capitalization	$3.8M
Today's Volume	$452.4K
52 Week High	$17.49
52 Week Low	$0.46
Revenue TTM	$431.4K
EBITDA	$-9.6M
Earnings Per Share (EPS)	$-0.62
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-37.4%

How to invest in Aptorum Group Ltd from India?

It is very easy for Indian residents to invest directly in Aptorum Group Ltd from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aptorum Group Ltd stock in both rupees (INR) and dollars (USD). Search for Aptorum Group Ltd or APM on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aptorum Group Ltd or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aptorum Group Ltd shares which would translate to 1.130 fractional shares of Aptorum Group Ltd as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Aptorum Group Ltd

211.11%

Period: Sep 6, 2024 to Dec 5, 2024. Change in 30 Days versus previous period

Investment in Aptorum Group Ltd from India has grown in the last 30 days as on Dec 6, 2024. 211.11% more purchase transactions for Aptorum Group Ltd in the last 30 days versus the previous period.

52%

Period: Sep 6, 2024 to Dec 5, 2024. Change in 30 Days versus previous period

Search volume for Aptorum Group Ltd on INDmoney from India has grown in the last 30 days as on Dec 6, 2024. 52% more investors are searching Aptorum Group Ltd in the last 30 days versus the previous period.

Global Institutional Holdings in Aptorum Group Ltd

Geode Capital Management, LLC
0.71%
Morgan Stanley - Brokerage Accounts
0.28%

Analyst Recommendation on Aptorum Group Ltd

Buy

83%Buy

16%Hold

0%Sell

Based on 6 Wall street analysts offering stock ratings for Aptorum Group Ltd(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Aptorum Group Ltd

What analysts predicted

Upside of 10566.67%

Current:

$0.75

Target:

$80.00

Insights on Aptorum Group Ltd

Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 48.5% return, outperforming this stock by 103.1%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.6% return, outperforming this stock by 142.5%

Aptorum Group Ltd Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$383.5K	-
Net Income	$-14.8M	↑ 482.22%
Net Profit Margin	-3.9K%	-

	FY19	Y/Y Change
Revenue	$535.2K	↑ 39.57%
Net Income	$-20.9M	↑ 40.61%
Net Profit Margin	-3.9K%	↓ 28.87%

	FY20	Y/Y Change
Revenue	$911.5K	↑ 70.32%
Net Income	$7.1M	↓ 133.89%
Net Profit Margin	775.29%	↑ 4672.13%

	FY21	Y/Y Change
Revenue	$1.5M	↑ 69.15%
Net Income	$-25.3M	↓ 457.84%
Net Profit Margin	-1.6K%	↓ 2415.5%

	FY22	Y/Y Change
Revenue	$1.3M	↓ 15.95%
Net Income	$-5.3M	↓ 78.98%
Net Profit Margin	-410.1%	↑ 1230.11%

	FY23	Y/Y Change
Revenue	$431.4K	↓ 66.71%
Net Income	$-2.8M	↓ 46.85%
Net Profit Margin	-654.8%	↓ 244.7%

	Q1 FY22	Q/Q Change
Revenue	$-1.3M	-
Net Income	$-2.2M	-
Net Profit Margin	177.14%	-

	Q2 FY22	Q/Q Change
Revenue	$527.5K	↓ 142.03%
Net Income	$-1.9M	↓ 15.19%
Net Profit Margin	-357.42%	↓ 534.56%

	Q1 FY23	Q/Q Change
Revenue	$768.4K	↑ 45.68%
Net Income	$-7.9M	↑ 319.8%
Net Profit Margin	-1.0K%	↓ 672.52%

	Q3 FY23	Q/Q Change
Revenue	$431.4K	↓ 43.86%
Net Income	$-5.5M	↓ 30.67%
Net Profit Margin	-1.3K%	↓ 242.05%

	FY18	Y/Y Change
Total Assets	$45.1M	↑ 42.82%
Total Liabilities	$12.3M	↑ 826.46%

	FY19	Y/Y Change
Total Assets	$24.0M	↓ 46.86%
Total Liabilities	$9.1M	↓ 26.17%

	FY20	Y/Y Change
Total Assets	$44.2M	↑ 84.65%
Total Liabilities	$6.1M	↓ 33.22%

	FY21	Y/Y Change
Total Assets	$21.9M	↓ 50.47%
Total Liabilities	$4.4M	↓ 27.6%

	FY22	Y/Y Change
Total Assets	$20.9M	↓ 4.75%
Total Liabilities	$13.0M	↑ 196.15%

	FY23	Y/Y Change
Total Assets	$20.6M	↓ 1.09%
Total Liabilities	$5.3M	↓ 59.67%

	Q4 FY22	Q/Q Change
Total Assets	$20.9M	↓ 13.12%
Total Liabilities	$13.0M	↑ 55.73%

	Q1 FY23	Q/Q Change
Total Assets	$20.9M	↑ 0.0%
Total Liabilities	$13.0M	↑ 0.0%

	Q2 FY23	Q/Q Change
Total Assets	$14.4M	↓ 30.94%
Total Liabilities	$1.6M	↓ 87.47%

	Q3 FY23	Q/Q Change
Total Assets	$14.4M	↑ 0.0%
Total Liabilities	$1.6M	↑ 0.0%

	Q4 FY23	Q/Q Change
Total Assets	$20.6M	↑ 43.21%
Total Liabilities	$5.3M	↑ 221.99%

	Q1 FY24	Q/Q Change
Total Assets	$20.6M	↑ 0.0%
Total Liabilities	$5.3M	↑ 0.0%

	FY18	Y/Y Change
Operating Cash Flow	$-10.0M	↑ 73.54%
Investing Cash Flow	$-6.1M	↓ 147.35%
Financing Cash Flow	$25.5M	↑ 180.54%

	FY19	Y/Y Change
Operating Cash Flow	$-13.4M	↑ 33.35%
Investing Cash Flow	$-108.1K	↓ 98.22%
Financing Cash Flow	$-7.3M	↓ 128.74%

	FY20	Y/Y Change
Operating Cash Flow	$-15.9M	↑ 19.05%
Investing Cash Flow	$1.8M	↓ 1804.74%
Financing Cash Flow	$12.4M	↓ 269.62%

	FY21	Y/Y Change
Operating Cash Flow	$-14.7M	↓ 8.04%
Investing Cash Flow	$16.5M	↑ 796.07%
Financing Cash Flow	$2.8M	↓ 77.61%

	Q1 FY22	Q/Q Change
Operating Cash Flow	$3.3B	↑ 0.0%
Investing Cash Flow	$1.4M	↑ 0.0%
Financing Cash Flow	$32.8B	↑ 0.0%

	Q2 FY22	Q/Q Change
Operating Cash Flow	$-6.8M	↓ 100.2%
Investing Cash Flow	$1.4M	↑ 0.0%
Financing Cash Flow	$3.0M	↓ 99.99%

Aptorum Group Ltd Technicals Summary

Sell

Neutral

Buy

Aptorum Group Ltd is currently in a neutral trading position according to technical analysis indicators.

Aptorum Group Ltd Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Aptorum Group Ltd	-36.47%	-80.8%	-56.89%	-94.88%	-99.44%
Regeneron Pharmaceuticals, Inc.	-8.09%	-23.99%	-10.23%	20.04%	108.5%
Biontech Se	5.61%	16.8%	14.99%	-61.28%	304.14%
Alnylam Pharmaceuticals, Inc.	-4.63%	65.6%	42.73%	40.34%	109.6%
Vertex Pharmaceuticals Incorporated	-6.83%	-3.58%	31.58%	126.94%	112.3%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Aptorum Group Ltd	NA	NA	NA	-0.64	-0.37	-0.32	NA	4.8
Regeneron Pharmaceuticals, Inc.	18.55	18.55	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.23	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Aptorum Group Ltd	Buy	$3.8M	-99.44%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$83.0B	108.5%	18.55	33.61%
Biontech Se	Buy	$28.9B	304.14%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	109.6%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$120.6B	112.3%	32.84	-4.51%

About Aptorum Group Ltd

aptorum group limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers. its pipeline through the establishment of drug discovery platforms enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. the company is also pursuing therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. it also has projects focused on surgical robotics and natural supplement for women undergoing menopause and experiencing related symptoms. aptorum group limited was incorporated in 2010 and is headquartered in london, the united kingdom.

Organization	Aptorum Group Ltd
Employees	3
CEO	Mr. Chung Yuen Huen
Industry	Health Technology

Management People of Aptorum Group Ltd

Name	Title
Mr. Chung Yuen Huen	Founder, CEO & Non-Executive Director
Mr. Kwok Kuen Wong	Head of Finance

Important FAQs about investing in Aptorum Group Ltd from India :

What is Aptorum Group Ltd share price today?

Aptorum Group Ltd (APM) share price today is $0.75.

Can Indians buy Aptorum Group Ltd shares?

Yes, Indians can invest in the Aptorum Group Ltd (APM) from India.

With INDmoney, you can buy Aptorum Group Ltd at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Aptorum Group Ltd at zero transaction cost.

How can I buy Aptorum Group Ltd shares from India?

It is very easy to buy Aptorum Group Ltd from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aptorum Group Ltd be purchased?

Yes, you can buy fractional shares of Aptorum Group Ltd with INDmoney app.

What are the documents required to start investing in Aptorum Group Ltd stocks?

To start investing in Aptorum Group Ltd, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.